The DRD4 7R 'risk gene' associated with novelty-seeking and risk-taking is present in roughly 48% of chromosomes in the Americas but only about 2% in East Asia.
Where this was said
At 1:32:18 · chapter starts 1:29:50
A Perplexity search about risk genes produces the striking finding that the DRD4 7R dopamine variant associated with novelty-seeking and risk-taking is roughly 24 times more common in American chromosomes than in East Asian ones, likely because the gene became prevalent among populations that migrated furthest from Africa. Sinclair, who has written about this in his next book, calls it the 'FU gene' — it activates in teenagers to push them out of the nest. This sparks a rich parenting discussion. Both men agree that the old model of authoritarian parenting creates distance and resentment. Rogan's method is radical honesty: telling his kids he has made every mistake they are making, so they experience him as a fellow traveler rather than a judge. Sinclair reflects that his first child, raised with more conventional discipline, is more distant than his third.
Approximately 150,000 people die every day worldwide from aging-related diseases, which motivates Sinclair's urgency in his research.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.